Anika Therapeutics (ANIK) Competitors $9.40 +0.17 (+1.79%) As of 11:45 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ANIK vs. ANVS, CERS, OSUR, UTMD, WST, COO, ALGN, MMSI, ICUI, and XRAYShould you be buying Anika Therapeutics stock or one of its competitors? The main competitors of Anika Therapeutics include Annovis Bio (ANVS), Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), and DENTSPLY SIRONA (XRAY). These companies are all part of the "medical" sector. Anika Therapeutics vs. Its Competitors Annovis Bio Cerus OraSure Technologies Utah Medical Products West Pharmaceutical Services Cooper Companies Align Technology Merit Medical Systems ICU Medical DENTSPLY SIRONA Anika Therapeutics (NASDAQ:ANIK) and Annovis Bio (NYSE:ANVS) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, earnings, profitability, valuation, dividends and risk. Does the media favor ANIK or ANVS? In the previous week, Anika Therapeutics had 1 more articles in the media than Annovis Bio. MarketBeat recorded 3 mentions for Anika Therapeutics and 2 mentions for Annovis Bio. Anika Therapeutics' average media sentiment score of 0.00 equaled Annovis Bio'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anika Therapeutics 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Annovis Bio 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals and insiders believe in ANIK or ANVS? 91.5% of Anika Therapeutics shares are owned by institutional investors. Comparatively, 15.8% of Annovis Bio shares are owned by institutional investors. 9.6% of Anika Therapeutics shares are owned by insiders. Comparatively, 20.8% of Annovis Bio shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has better earnings and valuation, ANIK or ANVS? Annovis Bio has lower revenue, but higher earnings than Anika Therapeutics. Anika Therapeutics is trading at a lower price-to-earnings ratio than Annovis Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnika Therapeutics$114.55M1.18-$56.38M-$4.15-2.27Annovis BioN/AN/A-$24.59M-$2.04-1.20 Which has more volatility & risk, ANIK or ANVS? Anika Therapeutics has a beta of 0.62, suggesting that its share price is 38% less volatile than the S&P 500. Comparatively, Annovis Bio has a beta of 1.63, suggesting that its share price is 63% more volatile than the S&P 500. Do analysts rate ANIK or ANVS? Anika Therapeutics presently has a consensus target price of $18.00, indicating a potential upside of 91.39%. Annovis Bio has a consensus target price of $17.33, indicating a potential upside of 608.64%. Given Annovis Bio's higher possible upside, analysts clearly believe Annovis Bio is more favorable than Anika Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Anika Therapeutics 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.67Annovis Bio 1 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.33 Is ANIK or ANVS more profitable? Annovis Bio has a net margin of 0.00% compared to Anika Therapeutics' net margin of -48.99%. Anika Therapeutics' return on equity of -10.97% beat Annovis Bio's return on equity.Company Net Margins Return on Equity Return on Assets Anika Therapeutics-48.99% -10.97% -8.51% Annovis Bio N/A -206.01%-158.26% SummaryAnnovis Bio beats Anika Therapeutics on 8 of the 15 factors compared between the two stocks. Get Anika Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ANIK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANIK vs. The Competition Export to ExcelMetricAnika TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$136.32M$12.30B$9.08B$10.58BDividend YieldN/A2.28%5.69%4.71%P/E Ratio-2.2821.9786.1627.45Price / Sales1.18273.38539.92202.26Price / Cash95.3047.1237.9261.55Price / Book0.8910.2813.056.77Net Income-$56.38M-$52.40M$3.30B$275.88M7 Day Performance3.13%6.10%4.55%2.63%1 Month Performance7.73%15.74%9.73%9.10%1 Year Performance-63.16%32.50%85.10%35.69% Anika Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANIKAnika Therapeutics4.2399 of 5 stars$9.41+1.8%$18.00+91.4%-62.5%$136.32M$114.55M-2.28300News CoverageAnalyst ForecastANVSAnnovis Bio2.4381 of 5 stars$2.25+1.1%$17.33+672.1%-72.7%$43.26MN/A-1.103News CoverageAnalyst ForecastGap UpCERSCerus2.3801 of 5 stars$1.61+2.5%$3.50+117.4%-2.3%$300.97M$180.27M-16.10290Positive NewsAnalyst ForecastShort Interest ↑OSUROraSure Technologies2.0704 of 5 stars$3.20+0.6%$3.00-6.3%-20.8%$232.58M$185.83M-4.78840News CoveragePositive NewsAnalyst ForecastUTMDUtah Medical Products2.5808 of 5 stars$62.72-0.9%N/A-2.5%$202.92M$40.90M16.77180News CoverageAnalyst ForecastWSTWest Pharmaceutical Services4.863 of 5 stars$268.21-1.6%$321.89+20.0%-6.5%$19.60B$2.89B40.1510,600Analyst ForecastCOOCooper Companies4.0251 of 5 stars$70.11-0.5%$84.75+20.9%-33.5%$14.01B$3.90B34.5416,000Analyst ForecastALGNAlign Technology4.8486 of 5 stars$131.50-0.5%$215.00+63.5%-43.1%$9.58B$4.00B22.1820,945Analyst ForecastMMSIMerit Medical Systems4.6896 of 5 stars$83.31-1.1%$107.50+29.0%-12.5%$4.99B$1.36B42.297,400Analyst ForecastICUIICU Medical4.4608 of 5 stars$121.38-0.6%$181.00+49.1%-32.5%$3.01B$2.38B-79.8515,000Positive NewsAnalyst ForecastXRAYDENTSPLY SIRONA4.8418 of 5 stars$12.52-5.1%$18.64+48.9%-49.4%$2.63B$3.79B-2.6414,000Analyst Forecast Related Companies and Tools Related Companies Annovis Bio Alternatives Cerus Alternatives OraSure Technologies Alternatives Utah Medical Products Alternatives West Pharmaceutical Services Alternatives Cooper Companies Alternatives Align Technology Alternatives Merit Medical Systems Alternatives ICU Medical Alternatives DENTSPLY SIRONA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ANIK) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA Huge Shift Is Underway in AmericaWall Street legend issues chilling new warning: "I've never seen anything as dangerous as this" The man who...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anika Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anika Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
